Deep Lens (acquired by Paradigm) logo

Deep Lens (acquired by Paradigm)

Accelerating clinical trial matching in oncology

5 employees · est. 2017 · Columbus, United States

VS
Outcomes4Me logo

Outcomes4Me

On a mission to democratize cancer patient care, one life at a time.

33 employees · est. 2017 · Boston, United States

Outcomes4Me is the larger of the two.

Side-by-Side Comparison

Deep Lens (acquired by Paradigm) Outcomes4Me
Founded
2017 2017
Headquarters
Columbus, United States Boston, United States
Employees
5 33 larger
Industry
AI, Health Care, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Unknown
Total Funding
$17.20M $39.90M
Funding Rounds
2 5
Services
Not tracked yet Personalized treatment plans, Symptom and medication management, Clinical trials discovery, Cancer-specific community support, Educational webinars
Target Customers
Not tracked yet Cancer patients, Oncology care providers, Life sciences companies, Healthcare professionals, Patient advocates
Taxonomy
Digital Healthcare, Clinical Trials, Oncology, AI-driven Platform, Cancer Patient Recruitment, Digital Pathology Workflow, AI Image Detection, Collaboration Platform, Cloud Storage, API Integration, Pathology Research, Pharmaceuticals, Cancer Research, Pathology AI-driven Healthcare Platform, Cancer Patient Care, Patient Empowerment, Real-time Clinical Information, Health Equity Promotion, Research Acceleration, Innovation Access, Digital Health, Breast Cancer, Healthcare Innovation, Oncology, Women-led Company, Healthcare Data Analysis, Healthcare Information Access
Website
deeplens.ai outcomes4me.com
Deep Lens (acquired by Paradigm) logo

About Deep Lens (acquired by Paradigm)

Deep Lens, with the slogan "Accelerating clinical trial matching in oncology," is a digital healthcare company that was established in 2017 and is headquartered in the United States. The company focuses on leveraging AI, machine learning, and life sciences to expedite the recruitment of suitable can...

Outcomes4Me logo

About Outcomes4Me

Outcomes4Me, founded in 2017 and headquartered in the United States, is at the forefront of democratizing cancer care through its innovative use of AI and machine learning technology. Their free platform empowers patients by offering personalized, FDA- and doctor-approved treatment insights tailored...

We will tell you when either one moves

BounceWatch watches Deep Lens (acquired by Paradigm) and Outcomes4Me for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Deep Lens (acquired by... and Outcomes4Me — by email.

Frequently Asked Questions

Deep Lens (acquired by Paradigm) — Accelerating clinical trial matching in oncology. Outcomes4Me — On a mission to democratize cancer patient care, one life at a time.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Deep Lens (acquired by Paradigm) has raised $17.20M while Outcomes4Me has raised $39.90M.
Deep Lens (acquired by Paradigm) and Outcomes4Me operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Deep Lens (acquired by Paradigm) with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Deep Lens (acquired by Paradigm) on 11 Sep 2024, and Outcomes4Me on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy